Alpha 2.0
Login Register
» Authors » S I Yamagishi

S I Yamagishi

Explore the profile of S I Yamagishi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 389
Followers 0
Related Specialties
General Medicine
Biochemistry
Endocrinology
Top 10 Co-Authors
X L Du
M Brownlee
D Edelstein
S Yagihashi
T C Hohman
H Ooka
C Yabe-Nishimura
H Adachi
T Nakamura
M Guzman
Published In
J Biol Chem
J Endocrinol Invest
Diabetes
Clin Exp Med
Brain
Affiliations
Soon will be listed here.
Recent Articles
1.
Ezetimibe reduces urinary albumin excretion in hypercholesterolaemic type 2 diabetes patients with microalbuminuria
Nakamura T, Sato E, Amaha M, Kawagoe Y, Maeda S, Inoue H, et al.
J Int Med Res . 2012 May; 40(2):798-803. PMID: 22613445
Objective: This study investigated the effects of ezetimibe, an inhibitor of intestinal cholesterol absorption, on early phase diabetic nephropathy. Methods: A total of 32 hypercholesterolaemic type 2 diabetes patients with...
2.
Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects
Nakamura K, Yamagishi S, Matsui T, Adachi H, Takeuchi M, Imaizumi T
Clin Exp Med . 2008 Jan; 7(4):188-90. PMID: 18188534
No abstract available.
3.
Ossifying gastric carcinoid tumor containing bone morphogenetic protein, osteopontin and osteonectin
Yamagishi S, Suzuki T, Ohkuro H, Yagihashi S
J Endocrinol Invest . 2005 Jan; 27(9):870-3. PMID: 15648553
We report a case of gastric carcinoid tumor with ossification. A 47-yr-old man complaining of abdominal discomfort underwent gastrointestinal endoscopic examination, which revealed a submucosal tumor in his stomach. The...
4.
Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor
Yagihashi S, Yamagishi S, Wada Ri R, Baba M, Hohman T, Yabe-Nishimura C, et al.
Brain . 2001 Nov; 124(Pt 12):2448-58. PMID: 11701599
The present study was designed to examine the effect of aldose reductase (AR) overexpression on the development of diabetic neuropathy by using mice transgenic for human AR. At 8 weeks...
5.
Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction
Yamagishi S, Edelstein D, Du X, Brownlee M
Diabetes . 2001 May; 50(6):1491-4. PMID: 11375352
Alteration of platelet function contributes to microthrombus formation and may play an important role in the pathogenesis of diabetic micro- and macroangiopathies. However, the molecular mechanism for platelet dysfunction observed...
6.
Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A
Yamagishi S, Edelstein D, Du X, Kaneda Y, Guzman M, Brownlee M
J Biol Chem . 2001 May; 276(27):25096-100. PMID: 11342529
Leptin, a circulating hormone secreted mainly from adipose tissues, is involved in the control of body weight. The plasma concentrations are correlated with body mass index, and are reported to...
7.
Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor
Yamagishi S, Yonekura H, Yamamoto Y, KATSUNO K, Sato F, Mita I, et al.
J Biol Chem . 1997 Mar; 272(13):8723-30. PMID: 9079706
This study was undertaken to determine whether and how advanced glycation end products (AGE), senescent macroproteins accumulated in various tissues under hyperglycemic states, cause angiogenesis, the principal vascular derangement in...